Multicentre evaluation of a nursing clinic for dyspnoea in patients with cancer of the lung
| ISRCTN | ISRCTN82994228 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN82994228 |
| Secondary identifying numbers | MPDU LU1 |
- Submission date
- 19/08/2002
- Registration date
- 19/08/2002
- Last edited
- 26/03/2020
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Cancer
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Plain English summary of protocol
Not provided at time of registration
Contact information
Dr - -
Scientific
Scientific
UKCCCR Register Co-ordinator
MRC Clinical Trials Unit
222 Euston Road
London
NW1 2DA
United Kingdom
Study information
| Study design | Randomised controlled trial |
|---|---|
| Primary study design | Interventional |
| Secondary study design | Randomised controlled trial |
| Study setting(s) | Not specified |
| Study type | Not Specified |
| Scientific title | Multicentre evaluation of a nursing clinic for dyspnoea in patients with cancer of the lung |
| Study objectives | Not provided at time of registration |
| Ethics approval(s) | Not provided at time of registration |
| Health condition(s) or problem(s) studied | Lung (non-small cell), Lung (small cell) |
| Intervention | 1. Control Group: Best supportive care plus breathing assessment 2. Intervention Group: Best supportive care, breathing assessment, breathing retraining and individual psychosocial support |
| Intervention type | Other |
| Primary outcome measure | Not provided at time of registration |
| Secondary outcome measures | Not provided at time of registration |
| Overall study start date | 01/01/2000 |
| Completion date | 31/12/2000 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Not Specified |
| Sex | All |
| Target number of participants | Not provided at time of registration |
| Key inclusion criteria | 1. Either sex any age 2. Small cell, non-small cell or mesothelioma of the lung 3. Completed first line therapy for the disease (surgery and/or chemotherapy and/or radiotherapy) 4. Change in breathing or a degree of breathlessness 5. Patients with metastatic disease are not excluded |
| Key exclusion criteria | Patients who have radiotherapy, chemotherapy or surgery planned for the 8 weeks that are required for the study, or who have had radiotherapy, chemotherapy or surgery in the last 3 weeks are excluded |
| Date of first enrolment | 01/01/2000 |
| Date of final enrolment | 31/12/2000 |
Locations
Countries of recruitment
- England
- United Kingdom
Study participating centre
UKCCCR Register Co-ordinator
London
NW1 2DA
United Kingdom
NW1 2DA
United Kingdom
Sponsor information
Macmillan Cancer Relief (UK)
Charity
Charity
89 Albert Embankment
London
SE1 7YQ
United Kingdom
| Website | http://www.macmillan.org.uk |
|---|---|
| https://ror.org/05vfhev56 |
Funders
Funder type
Charity
Macmillan Cancer Relief (UK)
No information available
Results and Publications
| Intention to publish date | |
|---|---|
| Individual participant data (IPD) Intention to share | No |
| IPD sharing plan summary | Not provided at time of registration |
| Publication and dissemination plan | Not provided at time of registration |
| IPD sharing plan |
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| Results article | results | 03/04/1999 | 26/03/2020 | Yes | No |
Editorial Notes
26/03/2020: Publication reference added.